Clinical Trial Update: The p53 Breast Cancer Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a p53-targeted breast cancer study, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Carcinoma

Snippet

Sponsor: Haukeland University Hospital | Conditions: Locally Advanced Breast Cancer, Metastatic Breast Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING